TB-500 (Thymosin Beta-4) in Australia: Regulatory and Research Context

Also known as: Thymosin Beta-4, TB4

What is TB-500?

TB-500, also known as Thymosin Beta-4 (TB4), is a naturally occurring peptide that has been the subject of international preclinical research. It is a synthetic version of a peptide naturally present in human cells. TB-500 is not currently listed on the ARTG for routine prescribing and remains under clinical investigation internationally. This page provides general information about TB-500's research and regulatory context and is not medical advice.

Regulatory Status in Australia

TB-500 is not currently TGA-approved for routine prescribing in Australia. It is not listed on the ARTG for any indication. Unapproved therapeutic goods may only be accessed through limited regulatory pathways, including the Special Access Scheme (SAS), Authorised Prescriber Scheme, or approved clinical trials. Each pathway requires involvement of an AHPRA-registered medical practitioner and has specific eligibility criteria and regulatory oversight requirements.

Research Context

Thymosin Beta-4 has been studied in preclinical research, including animal models and laboratory studies. Some early-phase human studies have been conducted internationally. The full safety and efficacy profile continues to be characterised, and findings from preclinical studies require further validation in controlled human trials before any conclusions about therapeutic use can be drawn. The research base does not currently constitute approval for routine clinical use in Australia.

What This Means for Australians

TB-500 is an investigational peptide not currently TGA-approved for routine prescribing
Access is limited to regulated pathways (SAS, Authorised Prescriber) with AHPRA-registered oversight
Discuss any interest in peptide therapy with a registered medical practitioner
Clinics listed on Peptide Finder can be compared by treatment focus including injury recovery
This information is general only - not medical advice

This page provides general information only and is not medical advice. Always speak with a qualified healthcare professional before starting any new medical treatment. Any prescribing decision is made by the treating practitioner after an individual clinical assessment.

Compare Clinics

34 clinics offering related consultations. Compare details, then contact the clinic that looks like the best fit.

Peptide Finder is a clinic directory only. We do not prescribe, supply, or advertise prescription medicines. Suitability is determined by the prescribing doctor at consultation.

Elite

GL Vitality Drips

Sydney, NSW

4.9(32)

Director-led, Australia-wide telehealth service connecting clients with AHPRA-registered doctors and licensed compounding pharmacies. Medical oversight is provided by Dr. Harrison Weisinger (Dr. Harry), an Australian family doctor with a PhD in preventative and evidence-based healthcare. Founded by Gemma - clients liaise directly with her throughout their program.

Injury RecoveryWeight ManagementMuscle & PerformancePlus more

Aus-wide delivery